glp 1 dental issues How GLP-1 Drugs Affect Your Mouth Ozempic teeth” are raising concern
Description
In addition, SGLT-2 inhibitors have shown benefit in patients with both HFrEF and HFpEF independently of diabetes status, which opens exciting possibilities for the use of these therapies in patients at risk for or with established CV or kidney disease without T2D
In addition, it is recommended that the duration of future clinical trials of GLP-1RAs for AD extend to 2 to 3 years to evaluate long-term outcomes, including changes in cognition, activities of daily living, instrumental activities of daily living, and biomarkers for tau and A
Learn how it works
A huge number of women starting GLP-1s are also in perimenopause, which is basically a hormonal obstacle course
Stepanova M, Rafiq N, Makhlouf H et al (2013) Predictors of all-cause mortality and liver-related mortality in patients with nonalcoholic fatty liver disease (NAFLD)
This Louisiana bill addresses a critical equity gap that I see every day in practice
